Heberprot-P
Injectable intralesional treatment for patients with severe diabetic foot ulcers.
Therapeutic Area
Diabetology
Active Ingredient
FCE Human Recombinant
Line
Diabetes + Oncology
Pharmaceutical Form
75 mcg lyophilized power x 6 ampoules
